Leveraging functional genomics to reveal novel targets for cancer treatment

P

Utilizziamo cookie essenziali, di analisi e pubblicitari per migliorare l'esperienza, misurare l'utilizzo e ottimizzare le campagne.

Maggiori informazioni su Informativa sulla privacy · Termini di Servizio · Cookie Policy

Description

Europe

Health & Life Sciences•100% • 3.2B€

Pending

Dates & Deadlines

Publication Date

Not defined

Opening Date

February 10, 2027

Application Phases

Fase única

September 16, 2027 at 05:00 PM

Financial Details

Non-Refundable

Maximum Funding Rate

100%

Budget

3.2B€

Eligible Project Value

7M€ - 8M€

Criteria & Documents

Eligible Expenses

●Personnel Costs
●Travel costs
●Equipment costs
●Other goods, works and services costs
●Subcontracting
●Indirect Costs

Access Conditions

●Legal entities from EU Member States and Associated Countries
●Consortium must include partners from at least three different EU Member States or Associated Countries
●Compliance with general and specific admissibility and eligibility criteria

Selection Criteria

●Excellence (scientific and technical merit)
●Impact (contribution to policy and partnership KPIs)
●Quality and efficiency of implementation

Mandatory Information

●Application form (Part A and Part B)
●Budget
●Ethics self-assessment

Result Indicators

●Scientific publications
●Clinical impact
●Data infrastructure established
●Societal benefits

EU Programme Details

Call ID: HORIZON-MISS-2027-02-CANCER-01
Cluster: Mission
Destination: Cancer
Submission Mode: Single-stage
EU Contribution: Around €7,000,000.00 to €8,000,000.00 per project
Expected Projects: 4 projects
Funding Rate Rule: Up to 100% of eligible costs for Research and Innovation Actions (RIA)

Funding Rate

100%

Budget

3.2B€

Curated by

Marlene Faria

Eligibility

Eligible Sectors

Health & Life Sciences

Company Typologies

MicroSMESmall Mid-CapMid-CapLargeNon-business entities of the R&I system (ENESII)Private non-profit entitiesPublic entities

Application Mode

Consortium / Copromotion

Action Types

Research and Innovation ActionsClinical TrialsDigital Health SolutionsCross-Border Integration

Official Links

Official Regulation